<DOC>
	<DOCNO>NCT02533154</DOCNO>
	<brief_summary>Benzalkonium chloride ( BAC ) preservative , component 70 % topical ophthalmic drug . Although BAC preservative excellent antibacterial spectrum , also show induce toxic effect ocular surface . Several study indicate BAC may also alter effect bacterial flora conjunctiva . Since dry eye syndrome ( DES ) common multifactorial disease ocular surface tear fluid result tear film instability , inflammation ocular surface , symptom discomfort visual impairment , many different preserve well preservative-free ophthalmic preparation ocular lubricant treatment DES . Unpublished data department show difference artificial tear treatment DES without BAC bacterial culture . Therefore , aim study investigate effect artificial tear eyedrop without BAC conjunctival bacterial flora . For 40 patient mild moderate dry eye syndrome use artificial tear 4 week precede study recruit treat either preservative-free `` Prosicca sine '' eyedrop BAC contain `` Prosicca '' eyedrops one month . Conjunctival sample collect one eye patient 1-month treatment period compare conjunctival bacterial flora two treatment group .</brief_summary>
	<brief_title>Effect Benzalkonium Chloride Containing Eye Drops Conjunctival Bacterial Flora Dry Eye Patients</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Benzalkonium Compounds</mesh_term>
	<criteria>Men woman age 18 75 year . Signed date write informed consent . History dry eye syndrome least 3 month Tear Break Up Time ( BUT ) ≤ 10 second Schirmer I test ≤ 10 mm ≥ 2mm Normal ophthalmic finding except dry eye syndrome , ametropia &lt; 6 Dpt . Recommended use topical lubricant , administration topical lubricant 4 week precede first study day . History presence ocular disease judge investigator incompatible study . Any topical ocular treatment study medication 4 week precede first study day treatment period . Wearing contact lenses . Symptoms clinically relevant illness 3 week first study day . Participation clinical trial 3 week precede first study day . Pregnancy , lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>